CDMO Blog

Scaling-Up Production of Pluripotent Stem Cells Part 2 – Key Considerations for Successful Scale-Up

close

Categories

See More

Subscribe to Email Updates

Popular Stories

Viral Aggregation in Downstream Processing of Lentiviral Vectors May 11, 2020
IQ, OQ and PQ: Why Are They Important in the Manufacturing of Cell and Gene Therapies? Oct 24, 2019
5 Considerations for Scaling-Up PSC-Derived Cell Therapies Mar 04, 2021
Five Steps to Ensure Your Cell and Gene Therapy Product Is GMP Compliant Oct 30, 2019
Planning Is Everything - Quality Control Testing in Cell and Gene Therapy Oct 30, 2019
Categories | Subscribe | Popular
09 Jun 2021

Scaling-Up Production of Pluripotent Stem Cells Part 2 – Key Considerations for Successful Scale-Up

In Part 1 of this series we covered some basic definitions and reviewe...

29 Oct 2019

How to Scale-Up Lentiviral Vector Production Part 1: Considerations for Upstream Processing

Lentiviral vectors (LVV) are a key component in the production of cell...

24 Oct 2019

What is a Bioreactor and How is it Used in Cell and Gene Therapy?

Simply put, a bioreactor is a stand-alone cell culture vessel enabled ...

Tell us what you thought about this post.
Business people meeting around table in modern space

Subscribe to our blog.

Receive updates on the latest trends in cell & gene therapy.

Subscribe to Email Updates

© 2021 All Rights Reserved